Ryan James, MacCraith Eoin, Davis Niall F, McLornan Liza
Urology Department, Connolly Hospital, Blanchardstown, Dublin, Ireland.
Urology Department, Austin Hospital, Melbourne, Australia.
Can Urol Assoc J. 2019 Nov;13(11):E371-E376. doi: 10.5489/cuaj.5750.
Nephron-sparing surgery (NSS) is the treatment of choice for T1 renal cell carcinoma (RCC). Since the first robotic assisted partial nephrectomy (RAPN) was performed in 2004, NSS is being implemented with increasing frequency. RAPN will likely become the gold standard procedure for T1 RCC due to improved dexterity, enhanced visualization, shorter learning curve, quicker recovery time, and shortened warm ischemic time. Although RAPN appears to be the preferred treatment for select renal tumours, there are notable complications in up to 35% of cases. While complications associated with RAPN are well-described, there is a lack of literature describing appropriate management strategies. Herein, we review complications associated with RAPN and design an appropriate systematic management algorithm.
保留肾单位手术（NSS）是T1期肾细胞癌（RCC）的首选治疗方法。自2004年首次开展机器人辅助部分肾切除术（RAPN）以来，NSS的实施频率越来越高。由于操作灵活性提高、视野增强、学习曲线缩短、恢复时间加快以及热缺血时间缩短，RAPN可能会成为T1期RCC的金标准术式。尽管RAPN似乎是某些肾肿瘤的首选治疗方法，但高达35%的病例会出现明显并发症。虽然与RAPN相关的并发症已有详细描述，但缺乏描述适当管理策略的文献。在此，我们回顾与RAPN相关的并发症，并设计一种适当的系统管理算法。
